Literature DB >> 31692816

One way to rule them all: G2/M gene regulation by oncogenic YAP1 and B-MYB.

Grit Weinstock1, Stefan Gaubatz1.   

Abstract

The Hippo pathway plays a major role in regulating organ size during embryogenesis. Loss of Hippo signaling can cause cancer due to unrestricted cell proliferation. Recently we found that Yes-associated protein 1 (YAP1), the major downstream effector of Hippo, promotes mitotic gene expression and proliferation through binding and activating the Myb-MuvB (MMB) complex subunit MYB proto-oncogene like 2 (B-MYB).
© 2019 Taylor & Francis Group, LLC.

Entities:  

Keywords:  B-MYB; MuvB; YAP1; cell cycle; enhancer; gene expression

Year:  2019        PMID: 31692816      PMCID: PMC6816428          DOI: 10.1080/23723556.2019.1648026

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

1.  A kinase shRNA screen links LATS2 and the pRB tumor suppressor.

Authors:  Katrin Tschöp; Andrew R Conery; Larisa Litovchick; James A Decaprio; Jeffrey Settleman; Ed Harlow; Nicholas Dyson
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

2.  Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.

Authors:  Avnish Kapoor; Wantong Yao; Haoqiang Ying; Sujun Hua; Alison Liewen; Qiuyun Wang; Yi Zhong; Chang-Jiun Wu; Anguraj Sadanandam; Baoli Hu; Qing Chang; Gerald C Chu; Ramsey Al-Khalil; Shan Jiang; Hongai Xia; Eliot Fletcher-Sananikone; Carol Lim; Gillian I Horwitz; Andrea Viale; Piergiorgio Pettazzoni; Nora Sanchez; Huamin Wang; Alexei Protopopov; Jianhua Zhang; Timothy Heffernan; Randy L Johnson; Lynda Chin; Y Alan Wang; Giulio Draetta; Ronald A DePinho
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

3.  The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes.

Authors:  Grit Pattschull; Susanne Walz; Marco Gründl; Melissa Schwab; Eva Rühl; Apoorva Baluapuri; Anita Cindric-Vranesic; Susanne Kneitz; Elmar Wolf; Carsten P Ade; Andreas Rosenwald; Björn von Eyss; Stefan Gaubatz
Journal:  Cell Rep       Date:  2019-06-18       Impact factor: 9.423

Review 4.  Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes.

Authors:  Martin Fischer; Gerd A Müller
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-08-11       Impact factor: 8.250

5.  YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers.

Authors:  Giorgio G Galli; Matteo Carrara; Wei-Chien Yuan; Christian Valdes-Quezada; Basanta Gurung; Brian Pepe-Mooney; Tinghu Zhang; Geert Geeven; Nathanael S Gray; Wouter de Laat; Raffaele A Calogero; Fernando D Camargo
Journal:  Mol Cell       Date:  2015-10-01       Impact factor: 17.970

Review 6.  Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway.

Authors:  Ursula Ehmer; Julien Sage
Journal:  Mol Cancer Res       Date:  2015-10-02       Impact factor: 5.852

7.  DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly.

Authors:  Larisa Litovchick; Laurence A Florens; Selene K Swanson; Michael P Washburn; James A DeCaprio
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

8.  Organ size control is dominant over Rb family inactivation to restrict proliferation in vivo.

Authors:  Ursula Ehmer; Anne-Flore Zmoos; Raymond K Auerbach; Dedeepya Vaka; Atul J Butte; Mark A Kay; Julien Sage
Journal:  Cell Rep       Date:  2014-07-10       Impact factor: 9.423

9.  Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.

Authors:  Francesca Zanconato; Mattia Forcato; Giusy Battilana; Luca Azzolin; Erika Quaranta; Beatrice Bodega; Antonio Rosato; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Nat Cell Biol       Date:  2015-08-10       Impact factor: 28.824

10.  Transcriptional integration of mitogenic and mechanical signals by Myc and YAP.

Authors:  Ottavio Croci; Serena De Fazio; Francesca Biagioni; Elisa Donato; Marieta Caganova; Laura Curti; Mirko Doni; Silvia Sberna; Deborah Aldeghi; Chiara Biancotto; Alessandro Verrecchia; Daniela Olivero; Bruno Amati; Stefano Campaner
Journal:  Genes Dev       Date:  2017-11-15       Impact factor: 11.361

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.